Loading the session
Loading the session
Loading instrument
$83.58
−4.94%DelayedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:18 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 4 Nov 2026 gain of 9.1% was 5.8× its average daily move of 1.6% over the past year, and its largest one-day gain since 26 Feb 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
1 month: +11.2% (SPY −1.6%, XLV +13.5%). 3 months: +11.3% (SPY −0.4%, XLV +15.5%). 1 year: +0.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: LMAT, SPY and XLV · as of 4 Nov 2026
1.8M shares were sold short at the 15 Oct 2026 settlement, 7.8% of the 22.9M shares outstanding; covering them would take 6.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
$0.25 a share, payable 3 Dec 2026; unchanged from the previous payment (ex-date 20 Aug 2026).
Corporate actions record · as of 5 Nov 2026
The 4 Nov 2026 close of $87.92 was 8.0% above its 50-day average ($81.38) and 6.9% below its 200-day average ($94.41). It has closed below the 200-day for 65 sessions, since 5 Aug 2026. The 50-day average crossed below the 200-day on 13 Aug 2026, 58 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
August 5, 2026
−25.32%February 26, 2026
+24.41%October 28, 2022
−19.09%